Mustang Bio, Inc. (MBIO): EPS (Diluted)
-$0.39
Year ended 2025-12-31
| Period ended | EPS (Diluted) | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$0.39 | n/m | 2026-03-19, From 2025-01-01 |
| 2024-12-31 | -$38.57 | n/c | 2026-03-19, From 2024-01-01 |
| 2023-12-31 | -$299.95 | n/m | 2025-03-28, From 2023-01-01 |
| 2022-12-31 | -$10.09 | n/m | 2024-03-11, From 2022-01-01 |
| 2021-12-31 | -$0.76 | n/a | 2023-03-30, From 2021-01-01 |
EPS (Diluted) at similar companies
| Company | Year ended | EPS (Diluted) | Change YoY |
|---|---|---|---|
| Mustang Bio, Inc. (MBIO) | 2025-12-31 | -$0.39 | n/m |
| Lisata Therapeutics, Inc. (LSTA) | 2025-12-31 | -$1.91 | n/m |
| Impact Biomedical Inc. (IBO) | 2025-12-31 | -$0.38 | n/m |
| Lipocine Inc. (LPCN) | 2025-12-31 | -$1.69 | n/a |
| Tempest Therapeutics, Inc. (TPST) | 2025-12-31 | -$6.33 | n/m |
| Galmed Pharmaceuticals Ltd. (EOCN) | 2025-12-31 | $2.39 | -70.4% |
| Aditxt, Inc. (ADTX) | 2025-12-31 | -$1153.83 | n/m |
| Genelux Corp (GNLX) | 2025-12-31 | -$0.86 | n/m |
| Marker Therapeutics, Inc. (MRKR) | 2025-12-31 | -$0.79 | n/m |
Compare MBIO, LSTA, IBO, LPCN side by side · Screen every company in Pharmaceutical Preparations ↗